KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Trevena, Inc. (NASDAQ: TRVN), a clinical stage biopharmaceutical company focused on the discovery and development of biased ligands targeting G protein coupled receptors, today announced it was added to the Russell 3000®, Russell 2000®, and Russell Global Indexes when the Russell Investment Group reconstituted its family of U.S. indexes after the stock market close on June 26, 2015.
Help employers find you! Check out all the jobs and post your resume.
